REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

Share Price Information for H&t Group Plc (HAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 430.00
Bid: 422.00
Ask: 439.00
Change: 5.00 (1.18%)
Spread: 17.00 (4.028%)
Open: 421.00
High: 430.00
Low: 420.00
Prev. Close: 425.00
HAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on regulatory review into HCST lending

4 Apr 2022 07:00

RNS Number : 0372H
H&T Group PLC
04 April 2022
 

H&T Group plc

("H&T" or "the Group" or "the Company")

 

Update in respect of regulatory review into high-cost short term lending

 

H&T Group plc announced on 18 November 2019 that it was working closely with the Financial Conduct Authority (FCA) to undertake via a skilled person, a review of the lending processes, credit worthiness and affordability assessments within its unsecured high-cost short term (HCST) loans business between April 2014 and October 2019 ("the review").

 

A methodology for conducting the required past book review was developed in close collaboration with the skilled person. Following an initial review by the FCA, "outcomes testing" was undertaken by the skilled person. After further review by the FCA and subsequent development of the methodology, the FCA has confirmed that H&T may now proceed to implementation of the past book review and the resulting customer redress arrangements.

 

Following application of the review methodology, it is considered that a total of c.9,800 HCST loans to c.8,000 customers should not have been granted. This represents 11.5% of HCST loans and 12.6 % of HCST customers during the period. Redress will be paid in respect of these loans in accordance with the methodology, including statutory interest up to 31 March 2022, taking account of any withholding tax.

 

In total, the cost of the redress will amount to £2.1m, of which £1.6m will be paid directly to customers and £0.5m will be by way of an adjustment to the balance of current outstanding loans. On average, eligible customers will receive redress amounting to £264.

 

Customers who are eligible to receive redress either in the form of cash or balance adjustment will be contacted directly, beginning in April 2022. The process is expected to be completed within 12 months.

 

A provision of £2.1m was raised in the Group's financial statements for the year ending 31 December 2021, to cover the cost of this redress. In addition, it is anticipated that professional, operational and implementation costs relating to the review and the redress programme will amount to approximately £0.6m. This has been fully provided for in previous accounting periods.

 

Chris Gillespie, chief executive of H&T said:

 

"The Board of H&T is very aware of the concerns and uncertainly that this review has caused for all stakeholders. We are pleased that the review is now concluded and that the majority of HCST loans granted by H&T are considered to have been lent responsibly.

 

"Customers whose loan should not have been granted and who are due redress, will be contacted directly and we will endeavour to complete the redress programme as quickly as we can, so as not to prolong the uncertainty further.

 

"H&T is committed to providing services which maintain the highest standards of customer care and regulatory compliance, and we have co-operated fully and constructively with the FCA throughout this review. High cost short term unsecured lending no longer forms part of the Group's product offering."

 

END

 

 

Enquiries:

H&T Group plc 

Tel: 020 8225 2797

Chris Gillespie, Chief Executive

Diane Giddy, Chief Financial Officer

 

Shore Capital Ltd (Nominated Adviser and Broker)

Tel: 020 7408 4090

Stephane Auton/ Iain Sexton (Corporate Advisory)

Guy Wiehahn/ Chloë Booker-Triolo (Corporate Broking)

 

Haggie Partners (Public Relations)

Tel: 020 7562 4444

Damian Beeley

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUMCCUPPGAG
Date   Source Headline
6th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:01 amRNSAcquisition of Swiss Time Services Limited
4th Jul 20227:00 amRNSTrading Update and Notice of Results
29th Jun 20226:18 pmRNSHolding(s) in Company
30th May 20227:00 amRNSPerformance Share Plan ("PSP") 2022
13th May 20227:00 amRNSResult of AGM
12th May 20227:00 amRNSTrading Update
3rd May 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20223:22 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSAppointment of non-executive director
4th Apr 20227:00 amRNSUpdate on regulatory review into HCST lending
25th Mar 20221:49 pmRNSHolding(s) in Company
8th Mar 20227:00 amRNSPreliminary results for the year ended 31 Dec 2021
17th Jan 20227:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20227:00 amRNSTrading Update and Notice of Results
20th Dec 20217:00 amRNSAnnouncement – Rule 17 Schedule 2(g) Updated
24th Nov 20219:52 amRNSDirector appointed
19th Nov 202112:08 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotification of major holdings
1st Nov 202110:22 amRNSH&T CFO appointment update
5th Oct 20212:30 pmRNSNotification of major holdings
10th Aug 20217:00 amRNSCorrection to Ex-Dividend and Record Date
9th Aug 20217:00 amRNSChief Finance Officer Appointment
9th Aug 20217:00 amRNSUnaudited Interim Results
21st Jul 20217:00 amRNSNotice of Interim Results
5th Jul 202111:56 amRNSPDMR Dealing
20th May 20213:00 pmRNSResult of Annual General Meeting
30th Apr 20217:00 amRNSBoard Changes - Chief Financial Officer
26th Apr 20217:00 amRNSPosting of Report & Accounts and Notice of AGM
23rd Mar 20217:00 amRNSPreliminary results for the year ended 31 Dec 2020
22nd Feb 20217:00 amRNSNotification of major holdings
25th Jan 20217:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
20th Nov 20207:00 amRNSDirector Dealings
9th Nov 20205:22 pmRNSChange of Auditor
5th Nov 202011:00 amRNSBusiness update
2nd Nov 20207:00 amRNSChange of Auditor
29th Oct 20207:00 amRNSH&T CEO appointment
26th Oct 20207:00 amRNSDirectorate Change
13th Oct 20204:35 pmRNSPrice Monitoring Extension
25th Sep 20207:00 amRNSDirector Dealings
25th Aug 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20208:37 amRNSTR-1: Notification of major holdings
13th Aug 20201:50 pmRNSAIM Rule 17 disclosure
11th Aug 20202:50 pmRNSInterim Results – Correction
11th Aug 20207:00 amRNSUNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS
22nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20204:35 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSH&T appoints Chris Gillespie as executive director
29th Jun 20207:00 amRNSCOVID-19 update
23rd Jun 20201:36 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.